Home/Ridgeline Therapeutics/Harshini Neelakantan, PhD

HN

Harshini Neelakantan, PhD

Exec. Director, Research & Development

Ridgeline Therapeutics

Therapeutic Areas

Metabolic Diseases Musculoskeletal Disorders Renal Disease

Leadership Team at Ridgeline Therapeutics

Stan Watowich, PhD

Suzanne Tomlinson, PhD, MBA

Director, Finance & Operations

View full Ridgeline Therapeutics profile